Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James B. Jones, MD, PharmD
Alpharma Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Michael Gibson, Md
Birmingham, Alabama, United States
- Michael Loes, Md
Phoenix, Arizona, United States
- Steven Siwek, Md
Phoenix, Arizona, United States
- Allan Soo, Md
Tempe, Arizona, United States
- Leah Schmidt, Do
Tucson, Arizona, United States
- Robert Burton, Md
Anaheim, California, United States
- Steve Sitar, Md
Anaheim, California, United States
- Arturo Palencia, Md
Bakersfield, California, United States
- Adam Karnes, Md
Beverly Hills, California, United States
- Douglas Haselwood, Md
Fair Oaks, California, United States
- Steven Croft, Md
Delray Beach, Florida, United States
- Roberto Rodriquez, Md
Hialeah, Florida, United States
- Orlando Florete, Md
Jacksonville, Florida, United States
- Michael Link, Md
Kissimmee, Florida, United States
- Miguel Trevino, Md
Largo, Florida, United States
- Diego Torres Ii, Md
Ormond Beach, Florida, United States
- Martin Hale, Md
Plantation, Florida, United States
- Margarita Nunez, Md
St. Petersburg, Florida, United States
- Mary Stedman, Md
Tampa, Florida, United States
- Raymond Tidman, Md
Blue Ridge, Georgia, United States
- Arnold Weil
Marietta, Georgia, United States
- Marvin Tark
Marietta, Georgia, United States
- Azazuddin Ahmed, Md
Chicago, Illinois, United States
- Jenecsis Castro-Skoglund, Md
Peoria, Illinois, United States
- Steven Elliott, Md
Evansville, Indiana, United States
- John Peppin, Do
West Des Moines, Iowa, United States
- Randall Brewer, Md
Shreveport, Louisiana, United States
- David Miller, Md
North Dartmouth, Massachusetts, United States
- Adnan Dahdul, Md
Springfield, Massachusetts, United States
- Rebecca Baumbach, Md
Saginaw, Michigan, United States
- Mel Lucas, Md
Florissant, Missouri, United States
- Anthony Margherita, Md
St Louis, Missouri, United States
- Randale Sechrest, Md
Missoula, Montana, United States
- John Jacobson, Md
Omaha, Nebraska, United States
- James Meli, Do
Henderson, Nevada, United States
- Stephen Miller, Md
Las Vegas, Nevada, United States
- Vrijendra Kumar, Md
Las Vegas, Nevada, United States
- Christopher Colopinto, Md
Voorhees Township, New Jersey, United States
- Barbara Mcguire, Md
Albuquerque, New Mexico, United States
- Arthur Elkind, Md
Mount Vernon, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2006
- Primary completion
- 31 Mar 2008
- Completion
- 31 Mar 2008
- Last update posted
- 20 Sept 2013
- Registered enrollment
- 467
- Registry id
- NCT00415597
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.